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When adding peroxide (H2O2), β subunits of hemoglobin (Hb) bear the burden of oxidative changes due
in part to the direct oxidation of its Cys93. The presence of unpaired α subunits within red cells and/or
co-inheritance of another β subunit mutant, HbE (β26 Glu-Lys) have been implicated in the patho-
genesis and severity of β thalassemia. We have found that although both HbA and HbE autoxidize at
initially comparable rates, HbE loses heme at a rate almost 2 fold higher than HbA due to unfolding of the
protein. Using mass spectrometry and the spin trap, DMPO, we were able to quantify irreversible oxi-
dization of βCys93 to reﬂect oxidative instability of β subunits. In the presence of free α subunits and
H2O2, both HbA and HbE showed βCys93 oxidation which increased with higher H2O2 concentrations. In
the presence of Alpha-hemoglobin stabilizing protein (AHSP), which stabilizes the α-subunit in a redox
inactive hexacoordinate conformation (thus unable to undergo the redox ferric/ferryl transition), Cys93
oxidation was substantially reduced in both proteins. These experiments establish two important fea-
tures that may have relevance to the mechanistic understanding of these two inherited hemoglobino-
pathies, i.e. HbE/β thalassemia: First, a persistent ferryl/ferryl radical in HbE is more damaging to its own
β subunit (i.e., βCys93) than HbA. Secondly, in the presence of excess free α-subunit and under the same
oxidative conditions, these events are substantially increased for HbE compared to HbA, and may
therefore create an oxidative milieu affecting the already unstable HbE.
Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The hemoglobin (Hb) tetramer consists of two pairs of α-globin
and β-globin subunits with one heme in each globin subunit. The
redox active heme/iron, forming the Hb oxygen (O2) binding site,
undergoes spontaneous and chemically induced oxidation reac-
tions. These events are well controlled under the reductive en-
vironment of normal red blood cells (RBCs). However, oxidation
reactions and the turnover of oxidation intermediates of cell-free
Hb in a number of chemically/genetically modiﬁed Hbs have been
the subject of intense investigations in recent years as theseaccess article under the CC BY-NC
d close to the alpha/beta in-
ntly oxidized by hydrogen
4106, 10903 New Hampshire
yash).oxidative pathways have been shown to contribute to the patho-
physiology associated with the use of Hb as oxygen therapeutics
and in some hemoglobinopathies [1–3].
Oxidants such as hydrogen peroxide (H2O2) drive a catalytic
pseudoperoxidase cycle that includes the formation of a transient
oxyferryl Hb, when the reaction starts with ferrous Hb. The ferryl
species autoreduces to ferric iron (Fe3þ) and in the presence of
additional H2O2, ferryl iron (Fe4þ) is regenerated back in a classic
cycle reported for both Hb and myoglobin (See Eqs (1–3)) [4].
When H2O2 reacts with the ferric form of Hb, a protein radical is
formed, but unlike true peroxidases this “unharnessed” radical is
escaped through βCys93 [5]. Both the ferryl heme and its asso-
ciated protein cation radical induce oxidative reactions affecting
the protein itself and other biological molecules due to their high
midpoint redox potentials, (E°1/21.0 V) [3]. These internal reac-
tions result in the modiﬁcation of heme, its subsequent attach-
ment to nearby amino acids, and the irreversible oxidation of
amino acids in oxidation “hotspot”, particularly the β Cys93 side--ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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dence from animal studies supports the notion that these oxida-
tive activities of Hb occur in vivo with some potentially serious
consequences [6,7].
HbFe2þO2þH2O2-HbFe4þ¼OþH2OþO2 (1)
= + → + + ( )+ + ⋅−HbFe O H O HbFe O H O 24 2 2 3 2 2
HbFe3þþH2O2-·HbFe4þ¼OþH2O (3)
Hb synthesis in erythroid progenitor cells is well controlled in
order to minimize the accumulation of free α-or β-Hb subunits,
which are cytotoxic. β-thalassemia is an autosomal recessive in-
herited disease causing anemia of variable degrees of severity in
Southeast Asia and the Mediterranean regions where in some
cases malaria is or has been endemic [8]. The molecular defects are
due to point mutations or small deletions within the chromosome
11 β-globin gene (or immediate ﬂanking regions of the Hb β gene)
leading to reduction or absence of β-globin chain synthesis. In the
latter scenario, unmatched α-Hb (because of its oxidative in-
stability) is particularly damaging to itself and other cellular pro-
teins, lipids, and nucleic acids [9,10]. This results in a short half-life
for circulating RBCs and also impairs the viability of erythroid
precursors in hematopoietic tissues, causing ineffective ery-
thropoiesis [11].
Hemoglobin E (HbE; 26Glu-Lys), is a common human Hb
variant, synthesized at a slightly reduced rate. Although HbE was
ﬁrst identiﬁed in the 1950s, there are still uncertainties regarding
its pathophysiology [12]. When it is inherited together with a β-
thalassemia allele, the resulting condition, HbE/β-thalassemia, is
often severe requiring a transfusion. HbE oxidative instability may
contribute to the severity and variability in HbE/β-thalassemia
[13]. The oxidative stress resulting from free α-chains within the
HbE/β-thalassemic RBC has been implicated in events that result
in HbE degradation and membrane damage [9,14,15]. In a study
involving 240 HbE/β thalassemia patients, those inheriting an α
deletion and/or point mutation were found to have mild symp-
toms, while patients with α triplication had severe phenotypes
requiring frequent transfusion. These observations seem to sug-
gest that the α globin levels are an important modiﬁer of HbE/β
thalassemia [16]. This is further supported by a mouse knock out
study comparing HbE knock out (KO) mice with HbE mice; the KO
mice lacked an abundance of α subunits that would approximate a
mouse thalassemia thereby supporting a model where HbE in-
stability is exacerbated by free α chains [17].
Overall HbE is structurally similar to HbA; however crystal
structural studies showed that, while intersubunit contacts remain
the same as those of HbA, the E26 K substitution results in the loss
of interactions required for optimal stabilized tertiary structure,
particularly at higher temperatures [18]. Recent structural and
functional comparisons between HbE and HbA (using high re-
solution x-ray crystallography, spectroscopy, and solution phase
circular dichroism) revealed substantial differences in nitrite re-
ductase activity and L-Cys-mediated reduction of metHb both in
the T and R states of HbE and HbA. These ﬁndings are consistent
with the HbE mutation causing an increase in the redox potential
of both the T and R states for this Hb [19].
α-Hemoglobin stabilizing protein (AHSP) is an erythroid sca-
venger protein (primarily expressed during erythropoiesis) that
rapidly and reversibly binds to monomeric forms of the α subunit.
AHSP binds in a 1:1 stoichiometry and has been shown to mod-
ulate heme iron oxidation and subunit folding [20,21]. The afﬁnity
of AHSP is dependent on the oxidation state; the rate of ferric α
dissociation from AHSP is dramatically slower than that for the
ferrous α subunit [21]. Recent mechanistic investigations ofisolated α and β subunits with H2O2 revealed that met-β subunits
are oxidized more prominently to form the ferryl heme species
and protein-based radicals than met-α subunits. Furthermore it
was shown that AHSP binding renders met-α Hb nearly inert to
oxidative degradation by H2O2, with no ferryl heme species or
protein-based radicals detected by either optical absorbance or
EPR. The AHSP binding dramatically lowers the redox potential of
α subunit to a much more negative value, and thermodynamically
favors the ferric over ferrous iron [21].
In this investigation, both HbE and HbA were contrasted in
their autooxidation reactions, and heme loss kinetics. Although
both HbE and HbA autooxidized initially at the same rate, HbE
loses heme more rapidly due to unfolding of the protein as the
reaction proceed to longer time periods. We also sought to de-
termine the precise role of free α subunits in destabilizing HbE and
HbA in solution under oxidative conditions. This however is ex-
perimentally challenging as α subunits, will exist at any given time
as α dimers or complexed with β subunits to form tetramers of
either HbE or HbA. We developed a mass spectrometry method
that speciﬁcally quantiﬁes the levels of irreversible oxidation of
hotspot residues including βCys93 in the presence of H2O2 in a
reaction mixture containing either HbE or HbA. Addition of free α
subunits to HbA or HbE in the presence of H2O2 resulted in a dose
dependent increase in the relative level of βCys93 oxidation in
both proteins. We also show that AHSP when complexed with α
subunits resulted in a complete reversal of oxidative damage
mediated by ferryl Hb.2. Experimental procedure
2.1. Protein puriﬁcation and handling
Fresh blood for HbA preparation was obtained by patient consent
from the Division of Transfusion Medicine, National Institutes of
Health. Human HbA was puriﬁed using established methods [22].
Speciﬁcally, HbA was puriﬁed using an XK50/100 column containing
Superdex 200 medium on an AKTA FPLC system to remove ery-
throcyte catalase [23]. Catalase activity assays were performed on Hb
samples to conﬁrm the complete removal of catalase [24]. Human
HbE was puriﬁed from red blood cells obtained from transgenic mice
expressing human HbE as described earlier [25]. Human HbE puriﬁed
from transgenic mouse RBC contains solely HbE, lacking con-
tamination from HbA2 as occurs in human red blood cells. Since
HbA2 and HbE have a very similar isoelectric point, separation is not
feasible, hence the advantage of human HbE expressed in the
transgenic full KO mouse. The criteria of purity of both proteins were
veriﬁed by isoelectric focusing and HPLC. The molar extinction
coefﬁcients used to calculate Hb concentrations in heme equivalents
in potassium phosphate buffer were 15.15 mM1 cm1 at 576 nm for
HbO2; 14.95 mM1 cm1 at 568.5 nm for HbCO in heme equiva-
lents; 4.4 mM1 cm1 at 630 nm for aquomet Hb in heme equiva-
lents; and 43.6 M1 cm1 at 240 nm for H2O2; 24 mM1 cm1 at
620 nm for sulfheme Hb in heme equivalents [26–28]. Both α and β
subunits were isolated using established methods [29]. AHSP used in
this study was a gift from Dr. Mitchell Weiss (Department of He-
matology, St. Jude Children's Research Hospital, Memphis, Tennessee,
USA). In the case of HbA and α/β subunits, previously determined
extinction coefﬁcients were used to determine protein concentra-
tions in heme equivalents. The AHSP extinction coefﬁcient utilized
was 11,460 M1 cm1 at 280 nm [29].
2.2. Spectrophotometry
The comparative oxidative stability of HbA and HbE were ex-
amined using an Agilent 8453 UV–visible light optical absorbance
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trophotometric studies listed below were performed with 65 mM
Hb (heme equivalents) in 20 mM potassium phosphate buffer, pH
7.4 at 37 °C. In the ﬁrst set of experiments, spectral scans in the
range of 450–700 were recorded every 2 min for 24 h to monitor
the impact of autooxidation (with and without catalase) on HbA
and HbE denaturation and precipitation. Speciﬁcally, any light
scattering associated with precipitation (and changes in turbidity)
was identiﬁed by increases in absorbance at 700 nm; importantly
oxyHb, metHb and hemichrome have little absorbance at this
wavelength.
A second set of experiments required multi-wavelength ana-
lysis to calculate accurate autooxidation rate constants due to
complications associated with HbE precipitation. Speciﬁcally, data
representing the absorbance at 540 nm, 560 nm, 576 nm, 630 nm
and 700 nm were recorded every 5 min for 24 h. The concentra-
tion and percentage of oxyHb (ferrous) were calculated using
multicomponent analysis as previously described [30]. Data for the
autooxidation experiments were normalized to total absorbance
signal changes, considering the 8th hour as maximum amount of
MetHb formation. Estimates of the autoxidation rate constants
were obtained by ﬁtting the initial phase (8 h) of the normalized
absorbance decreases at 576 nm to a single-exponential expres-
sions: y¼ymax * ektþy0, where y is the observed absorbance
reading as a function of time. The time courses were ﬁtted using
the Excel Microsoft Solver program. In a third set of experiments,
H2O2 mediated ferryl Hb formation for HbA and HbE was mon-
itored upon the addition of 30 equivalents of H2O2 (30% (w/w))
After a reaction time of 2 min, catalase (200 units/mL) was added
(for 1 min) to remove excess H2O2 followed by ferryl detection
using 2 mM sodium sulﬁde (Na2S was added to transform ferryl
Hb to sulfHb). Visible light optical absorbance spectra were re-
corded between 500 and 700 nm. The concentration of sulfHb was
calculated using the extinction coefﬁcient of sulfheme listed
above.
2.3. Kinetics of ferryl hemoglobin decay
MetHb (ferric) was freshly prepared prior to the start of each
experiment. From a 1.5 mM stock solutions of HbO2 to which slight
molar excesses of K3[Fe(CN)6] was added to generate metHb. Re-
moval of K3[Fe(CN)6] was accomplished using a column containing
Sephadex G-25 media (Sigma-Aldrich, St. Louis, Missouri, US).
Ferryl HbA and HbE were generated by the addition of 10, 30, or 50
heme equivalents of H2O2 to metHb (65 μM) in 50 mM phosphate
buffer pH 7.4 to ensure maximum ferryl production in the Hb
solutions. After 2 min of reaction time, excess catalase (250 units)
was added to stop the reaction and to prevent heme bleaching.
Decay of the resulting ferryl species back to metHb was followed
at ambient temperature. Spectra were recorded between 500 and
700 nm for 1 h, scanning every 30 s. The optical changes were
monitored and the time courses for reduction of ferryl Hb were
plotted as absorbance (541 nm or 544 nm) and (630 nm) versus
time (seconds) and ﬁtted to a single exponential function using
Microsoft Excel.
2.4. RPHPLC globin chain analyses after peroxide treatment
RP-HPLC was performed with a Zorbax 300 SB C3 column
(4.6250 mm) using Waters HPLC system consisting of a Waters
626 pumps, 2487 dual-wavelength detector and a 600 s controller
installed with Empower 2 (Waters Corp, Milford, MA). 20 μg of Hb
in 25 mL of water was loaded on the C3 column equilibrated with
35% acetonitrile containing 0.1% TFA. Globin chains were eluted
with a gradient of 35–50% ACN within 100 min at a ﬂow rate of
1 mL/min. The eluent was monitored at 280 nm for globin chainsand at 405 nm for the heme components. For the H2O2 oxidation
experiments, 250 mM of Hbs (in 1 mL of 50 mM phosphate buffer,
pH7.4) were oxidized with escalating does of H2O2 (0.25, 0.55,
0.75, 1.25, 2.5, 5.0, and 10.0 mM) at 25 °C. Catalase (70 mL) in PBS
(37,840 U/mL, MP Biomedical) was added into the 1 mL of reaction
solution at 1 h to terminate the oxidation reactions.
2.5. Kinetics of heme loss from hemoglobins
To assess the rate of heme transfer, we measured the absor-
bance changes when a heme acceptor, a double-mutant (H64Y/
V86 F) apomyoglobin (ApoMb), binds the heme released from HbA
and HbE to yield holomyoglobin, a green adduct [31]. In these
experiments, spectra between 350 and 800 nm were recorded
every 2 min for 16 h at 37 °C using 200 mM potassium phosphate
buffer, 600 mM sucrose, at pH 7.0. Final concentration of Hb in
heme equivalents was 2 μM and the ﬁnal concentration of H64Y/
V86F ApoMb was 20 μM in a 1 mL total reaction volume. Data
collection started immediately after mixing the two solutions.
2.6. Mass spectrometric analysis of hemoglobin subunits oxidation
reactions with and without AHSP
MS experiments were performed with 178 μM (heme) HbA and
HbE and were carried out after incubation overnight in 20 mM
phosphate buffer, pH 7.4 at ambient temperature. The following 10
experimental conditions were designed to study the effect of ex-
cess α subunits (associated with β thalassemia) and increasing
H2O2 concentration on HbA and HbE oxidation in the presence and
absence of AHSP: (experiments 1) (control) ferrous HbE and HbA
were incubated in air equilibrated phosphate buffer; (experiments
2) ferrous HbA and HbE were incubated with 2.0 M excess of H2O2
per heme; (experiments 3–4) ferrous HbA and HbE were in-
cubated with equimolar ferric alpha Hb subunits and 2.0 and 5.0 M
excess of H2O2 per heme; (experiments 5–6) ferrous HbA and HbE
were incubated with equimolar ferric alpha Hb subunits, equi-
molar AHSP and 2.0 and 5.0 M excess of H2O2 per heme; (ex-
periments 7–8) ferrous HbA and HbE were incubated with equi-
molar ferrous alpha Hb subunits and 2.0 and 5.0 M excess of H2O2
per heme; (experiments 9–10) ferrous HbA and HbE were in-
cubated with equimolar ferrous alpha Hb subunits, equimolar
AHSP and 2.0 and 5.0 M excess of H2O2 per heme.
2.7. Spin trapping reaction conditions
HbA or HbE (65 mM in heme), in 100 mM ammonium bi-
carbonate, pH 8.0 were subjected to both a 5 fold and 10 M excess
of H2O2 over heme in the presence of DMPO (5,5-Dimethyl-1-
Pyrroline-N-Oxide) at 37 °C for 2 h. The reactions were stopped by
freezing at 80 °C. All samples were prepared for LC-MS/MS
analysis as described below.
2.8. LC-MS/MS analysis
All Hb samples were tryptically digested, desalted and analyzed
by mass spectrometry using our previously described method. [32]
Brieﬂy, tryptic peptides were analyzed by reverse phase liquid
chromatography mass spectrometry (RP LC/MS/MS) using an Easy
nLC II Proxeon nanoﬂow HPLC system coupled online to a Q-Ex-
active Orbitrap mass spectrometer (Thermo Scientiﬁc). Data were
acquired using a top 10 method (for 60 min) dynamically choosing
the most abundant precursors (scanned at 400–2000m/z) from
the survey scans for HCD fragmentation.
Data were searched against the Swiss-Prot Human database
(release 2014_03; contains 542,782 sequence entries) supple-
mented with HbE and porcine trypsin using the Mascot (version
Table 1
Observed rate constants for the initial phase of Hb autooxidation in phosphate
buffer (n¼3).
Sample kauto (h1) kauto (h1)þCatalase
HbA 0.05470.0024 0.00770.003
HbE 0.05170.056 0.08970.0016
M.B. Strader et al. / Redox Biology 8 (2016) 363–3743662.4) search engine (Matrix Sciences, London, UK) as described
previously [32] with the following amendments to Mascot sear-
ches: variable modiﬁcations including cysteine trioxidation
(þ48 Da), cysteine dioxidation (þ32 Da), tryptophan oxidation
(þ16), tyrosine oxidation (þ16 Da), and methionine oxidation
(þ16) were included for identifying “hotspot” oxidation and
DMPO labeled cysteine and tyrosine (þ111 Da) were included as
variable modiﬁcations for all DMPO treated samples. Mascot out-
put ﬁles were analyzed using the software Scaffold 4.2.0 (Pro-
teome Software Inc.). Hb peptide identiﬁcations were accepted if
they could be established at greater than 99.9% probability and
contained at least 2 identiﬁed peptides. Peptide probabilities were
assigned by the Protein Prophet algorithm [33].2.9. Quantitative mass spectrometric analysis
Peptides listed in Table 2 from LC-MS/MS data were analyzed to
quantify changes in HbE and HbA under the oxidative conditions
for experiments 1–10 (listed above). Each peptide was further
validated by retention time reproducibility. All quantitative ex-
periments were performed in triplicate and standard deviations
were obtained by averaging relative abundance data from three
different experiments. Brieﬂy, extracted ion chromatograms (XICs)
were generated from the most abundant monoisotopic peak of
each isotopic proﬁle (representing charged states of each peptide).
To construct XICs, Xcalibur (version 2.2) software was used with a
designated mass tolerance of 0.01 Da, and mass precision set to
three decimals. For relative quantiﬁcation, the ratio of each iso-
formwas calculated based on the sum of the XIC peak area from all
forms (including all charge states and versions that result from
different cleavage sites), which was normalized to 100%.Table 2
All Hotspot peptides including charge state and cleavage variants derived from HbA
and HbE.
Peptides Modiﬁed
residue
(þ)
Charge
State
m/z
83GTFATLSELHCDK96 βCys93 2 735.33
83GTFATLSELHCDKLHVDPENFR104 βCys93 3 860.06
4 645.31
31LLVVYPWTQR40 βTrp37 2 645.86
9SAVTALWGK17 βTrp15 2 476.76
105LLGNVLVCVLAHHFGK121 βCys112 3 589.99
2 884.48
32MFLSFPTTK40 αMet32 2 544.27
2 1087.54
41FFSFGDLSTPDAVMGNPK59 βMet55 3 692.32
2 1037.97
17VGAHAGEYGAEALER31 αTyr24 3 525.58
41TYFPHFDLSHGSAQVK56 αTyr42 3 626.97
4 470.48
62VADALTNAVAHVDDMPNALSALSDLHAHK90 αMet76 2 628.92
3 524.26
100LLSHCLLVTLAAHLPAEFTPAVHASLDK127 αCys104 4 754.66
Fig. 1. Autooxidation kinetics of HbA and HbE. Spectral changes were measured
during the autooxidation of 65 μM (heme) HbA and HbE in 20 mM phosphate
buffer, pH7.4 at 37 °C, and monitored in an Agilent 8453 spectrophotometer. Panels
A (HbA)-B HbE): represent time dependent spectra measured every hour up to 16 h
during autooxidation. Panel C represents the same conditions for HbE in the pre-
sence of 200 units catalase.3. Results
3.1. Autooxidation kinetics of HbA and HbE
We monitored spectral scans in the range of 450–700 nm every
2 min for 24 h. Panels A-C in Fig. 1 represent hourly time depen-
dent spectra (up to 16 h) that were taken at 37 °C during the au-
tooxidation of 65 mM HbA and HbE (in heme equivalents). Since
HbO2, metHb and hemichromes have little absorbance at 700 nm
any increases in absorbance at 700 nm is purely due to light
Fig. 2. Spectral analysis of hydrogen peroxide oxidation reaction with ferrous HbA
and HbE and the formation of their respective sulfhemoglobin. Absorbance spectra
were recorded before and after the addition of 2 mM Na2S to 65 mM HbA (Panel A)
and HbE (Panel B) in solutions containing 30 equivalent of H2O2. The spectra
(shown in both panels) with λmax at 541 nm and 576 nm are representative for
ferrous heme (Fe2þ) before the addition of H2O2. The spectra shown in both panels
characterized by peaks at 544 and 585 nm corresponds to the transient ferryl Hb
spectrum (characterized by peaks at 544 and 585 nm) immediately after the ad-
dition of H2O2. To further verify the ferryl intermediate Na2S was added to trans-
form ferryl Hb to form sulfHb which exhibits a characteristic strong peak at
620 nm.
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Panel A (representing HbA) show an increase in absorbance at
630 nm but little if any increase at 700 nm. The increase at 630 nm
(λmax for ferric Hb) is associated with oxidation of the ferrous
(Fe2þ) to the ferric (Fe3þ) state. Conversely, the spectra in Panel B
(representing HbE) clearly show an increase in absorbance at
630 nm and 700 nm indicating both the formation of ferric HbE
and protein denaturation/precipitation. Notably, the HbA spectra
(Panel A) maintained clear isosbestic points (unlike those shown
for HbE), reﬂecting the speciﬁc transition of ferrous to ferric heme.
In the case of HbE (after 6–8 h) there was a clear deviation in
spectra from the isosbestic points reﬂecting the onsets of protein
unfolding/denaturation. The addition of catalase to HbE eliminates
the observed denaturation (see Fig. 1, Panel C) verifying that
precipitation seen in Panel B is directly linked to the autooxidative
production of H2O2.
Due to complications associated with HbE precipitation, multi-
wavelength analysis was employed to subtract out the elevated
absorbance at 700 nm due to unfolding and precipitation in order
to obtain accurate autooxidation rate constants (see Experimental
Procedures). Estimates of the autooxidation rate constants were
obtained by ﬁtting the initial linear portion of the time courses
(ﬁrst 8 h) to a single exponential expression. The autooxidation
rate constants listed in Table 1 show nearly identical kauto values of
0.051 h170.0021 and 0.054 h170.0067 for HbA and HbE re-
spectively. The HbA rate constant reported in this work is similar
to previously reported rates by our group under similar conditions
[32]. Autooxidation rates for both Hbs were substantially reduced
by nearly identical levels with the use of 200 units of catalase in
each sample. The identical kauto rate constants taken together with
the above spectral scan data (represented in Fig. 1 Panels A-C)
indicate that the autooxidation kinetics for both are similar.
However, the accumulation of oxidants (H2O2) during spontaneous
oxidation is not the same among the two proteins in the presence
of identical levels of catalase (Table 1). This suggests that the
structural impact of autooxidation is more profound for HbE, in
keeping with previous observations on oxidatively less stable Hbs
[35,36].
3.2. Peroxide-mediated ferryl formation
The pseudoperoxidase reactivity of both Hbs with H2O2 was
examined using UV/Vis absorbance spectroscopy, with the for-
mation of the oxo-ferryl heme species monitored by absorbance
changes in the visible spectrum (see Eqs. (1–3)). Fig. 2 shows ty-
pical spectral transitions for ferrous HbA and the HbE mutant after
a 2 min incubation with 30 fold excess H2O2; the ferryl species is
characterized by major peaks at 544 and 585 nm and a ﬂattened
region between 600 and 650 nm (Panels A and B) (equation 1). To
conﬁrm the spectral identity of the ferryl species, Na2S was added
to the reaction mixture and sulfheme formation was followed by
the appearance of an absorbance band at 620 nm. Catalase was
added prior to the addition of sulﬁde to remove any excess H2O2 so
that any sulfur addition to the heme group was due only to reac-
tion with ferryl heme complexes. In these experiments, the levels
of ferryl Hb in HbA and HbE were estimated to be 20.2 and
20.4 μM, respectively, based on the reported extinction coefﬁ-
cients for sulfheme [28]. These spectral changes, like the auto-
oxidation kinetics reveal nearly identical levels of ferryl HbA and
HbE after incubation with H2O2.
3.3. Hydrogen peroxide induced oxidative changes in hemoglobins
One of the properties of the Hb ferric/ferryl redox cycle is
subunit oxidative changes that can be detected by HPLC. The H2O2
speciﬁc impact on HbA and HbE were evaluated using an RP-HPLCmethod such that the absorbance at 280 and 405 nmwas recorded
to monitor protein and heme components of Hb, respectively. As
shown in Fig. 3A, the α-globin chains, β-globin chains, and heme
moieties of untreated HbA were separated into three distinct
peaks. Under our chromatographic conditions, the HbA β and α
chains eluted at 42.5 and 46.5 min, respectively, and the HbE β and
α chains eluted at 38 and 46.5 min, respectively. There was a
corresponding decrease in peak height of α and β subunits with
increasing H2O2 (Figs. 3A and B). Based on peak integration and
the retention time of each subunit we were able to plot retention
fraction of each subunit as function of heme: H2O2 ratios as shown
M.B. Strader et al. / Redox Biology 8 (2016) 363–374368in Fig. 3C. As can be seen, the β subunit retention fractions are
much lower than α subunit fractions (in both proteins), indicating
that the β subunit is more prone to oxidative damage. As shown in
Fig. 3 (A and B), HbE is more susceptible to oxidative changes thanHbA upon treatment with higher concentrations of H2O2. These
results are also consistent with our previous observation which
conﬁrms that H2O2 induces extensive decomposition of β-globin
chains of Hb [5].
3.4. Autoreduction rates of ferryl HbA and HbE and decay to
methemoglobin
To explore possible differences in ferryl Hb autoreduction rates,
we followed the autoreduction (ferryl decay) of ferryl HbA and
HbE to their respective ferric states at varying H2O2 concentra-
tions. Ferryl decay was followed at room temperature by mon-
itoring changes in absorbance at 541 nm and 544 nm as a function
of time and observed to be identical. Any observable rate variance
between HbA and HbE, as monitored through the decrease of
ferryl and increase in ferric heme, reﬂected differences in auto-
reduction rate constants. While ferryl decay differences were un-
detectable at a majority of the H2O2 concentrations studied, we
were able to see a clear difference in the ferryl decay time courses
for ferryl HbA and HbE after treatment with 50 M excess H2O2
(Fig. 4). Indeed, the decay of the ferryl species is clearly slower for
HbE than HbA indicating that the former has a lower autoreduc-
tion rate constant. The time courses for ferryl HbE decay were ﬁt to
a single exponential expression with a rate constant equal to
1.3770.08 h1, compared to 5.0570.17 h1, for HbA; the ferryl
decay rate of HbA was 3.4 times slower than the calculated rate for
HbE solutions (Fig. 4C). The inset to Panel 4 C further substantiates
the ferryl decay results; the transition back to metHb (monitored
at 630 nm) is much slower for HbE. Although extremely high H2O2
levels were required to detect differences, these results suggest
that ferryl HbE likely persist longer and as a result is oxidatively
less stable and more damaging to it and other biological
molecules.
3.5. Kinetics of heme loss from HbA and HbE
In order to further probe the apparent difference in structural
stability, we performed experiments to determine the rates of
heme loss for both HbA and HbE. Typical spectral changes occur-
ring during heme exchange between metHbA and H64Y/V86 F, the
receptor apomyoglobin, are shown in Fig. 5, Panel A and B. The
heme transfer is conﬁrmed by the red shift in the Soret peak and
the appearance of a new peak at 600 nm. Time courses for heme
loss measuring the decrease in A410 nm as heme is transferred to
the H64Y/V68 F apoMb reagent are shown in Fig. 5 Panel C. As
shown in earlier reports, the time courses in this study were bi-
phasic with fast components represent heme loss from β-subunits
of both proteins [37]. Unlike HbA, an increase in absorbance at
extended time reﬂects aggregation of the HbE apoglobin. Esti-
mates of averaged absorbance changes at the Soret peak at 410 nm
were normalized and the initial phases of absorbance were ﬁt toFig. 3. RP-HPLC analyses of oxidative changes in hemoglobin A and hemoglobin E
and the retention fractions of their subunits as a function of peroxide concentra-
tion. Panel A and B represent RP-HPLC chromatograms of HbA and HbE treated
with different H2O2 concentrations. RP-HPLC was performed using a Zorbax 300 SB
C3 column (4.6250 mm). Hbs (250 mM in heme) were incubated in 20 mM
phosphate buffer pH 7.4, 25 °C in the presence or absence of 0.25, 0.5, 0.75, 1.25,
2.5, 5.0, and 10.0 mM H2O2. 70 mL of catalase (0.57 mg/mL) was added to 1 mL of
reaction solution to terminate the oxidation reactions. Oxidized Hb samples (40 mL)
were loaded into the autosampler of Waters HPLC. Panel C, represents a plot of the
reaction fraction of Hb solutions (%) versus the ratios of Hb: H2O2 used. The open
circle and square represent the α and βA chains of HbA. The closed circle and square
represent the α and βE chains of HbE. The values in (C) were derived from the areas
of β and α chains for each Hb from panel A and B. The area of each peak was
integrated with Origin 6.0 software. The retention fraction of each peak was cal-
culated by dividing the area of the subunit peak subjected to oxidation with the
area of the subunit peak without oxidation.
Fig. 4. Oxidative stability of the ferryl intermediate in HbA and HbE and auto-
reduction to the ferric forms. Samples of 65 μM metHbA or metHbE were initially
incubated with 3.25 mM H2O2 for 2 min 20 mM phosphate buffer, pH 7.4 at 25 °C.
After the addition of catalase (250 units) to stop the reaction, absorbance spectra
were recorded at intervals of 30 sec for 1 h within 350 nm and 700 nm. Spectral
Panels A-B: time dependent spectra representing the ﬁrst and ﬁnal (56 min) re-
corded spectra during the ferryl decay of HbA (A) and HbE (B). Panel C: Ferryl decay
was evaluated by plotting changes in absorbance at 541 nm as a function of time.
The resulting ferryl decay time courses for metHbA and metHbE were ﬁt to a single
exponential expression (open and closed circles represent HbA and HbE respec-
tively). Inset to Panel C: MetHb formation time courses were evaluated by plotting
changes in absorbance at 630 nm (open and closed circles represent HbA and HbE
respectively).
Fig. 5. Time courses for heme dissociation from ferric HbA and HbE. Samples of
2 μM metHb were mixed with 20 μM H64Y/V86 F apomyoglobin in 200 mM po-
tassium phosphate buffer at pH 7, 37 °C, containing 600 mM sucrose and the
transfer of heme to the apoMb reagent was followed at 410 nm. Panel A represents
exemplary absorbance spectrum for holoMb (H64Y/V86 F) with HbA. Panel B re-
presents exemplary absorbance spectrum for holoMb (H64Y/V86 F) with HbE. Pa-
nel C represents absorbance changes at 410 nm plotted as a function of time for 3 h
for HbA (open circles) and HbE (closed circles).
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Table 3
Quantitative mass spectrometry data representing control oxidative reactions of
ferric HbA and HbE with H2O2.
Reaction conditions HbA Cys93 Oxidation (%) HbE Cys93 Oxidation (%)
No H2O2 0.670.05 0.270.05
2XH2O2 3.070.2 4.070.1
5XH2O2 8.670.12 8.170.03
M.B. Strader et al. / Redox Biology 8 (2016) 363–374370double exponential decay expressions where k1 and k2 are the fast
and slow ﬁrst-order observed rate constants. Rate constants equal
to, k1¼11.75 h1 and k2¼0.86 h1 were derived for metHbA and
were similar to the reported rates for normal HbA [23]. Rate
constants for the heme transfer from HbE were k1¼19.07 h1and
k2¼2.12 h1 respectively. These results conﬁrm that HbE loses its
heme about 1.5–2.0-fold faster than HbA. Taken together with the
autooxidation, slower decay of the ferryl heme data described
above suggest that oxidative changes within HbE leads to rapid
denaturation and subsequent heme loss.
3.6. Quantitative mass spectrometry analysis of amino acids oxida-
tion in hemoglobins
To investigate the impact free α subunits have on HbA and HbE
oxidative stability, we utilized a quantitative mass spectrometric
strategy aimed at exploring the consequential post-translational
modiﬁcation of "oxidation hotspots" for both Hbs under increasing
H2O2 conditions. Speciﬁcally, HbA and HbE were incubated with
either ferric or ferrous free α subunits with increasing H2O2 con-
centrations. To further substantiate the effect free α subunits have
on H2O2 induced oxidation, we also included these experimental
conditions in the presence of alpha hemoglobin stabilizing protein
(AHSP) as described below.
LC/MS/MS analysis was utilized to target all “hotspot” peptide
charge states reproducibly identiﬁed by Mascot database searches
(see Table 2). Amino acids residues identiﬁed by LC-MS/MSFig. 6. Isotopic proﬁle and extracted ion chromatogram (XIC) of βCys93 tryptic peptide
proﬁle. To construct XICs, Xcalibur (version 2.2) software was used with a designated
quantiﬁcation, the ratio of each isoform was calculated based on the sum of the XIC p
different cleavage sites), which was normalized to 100%. Top Panel A represents the isot
and the representative XIC of βC93 tryptic peptide (residues 83–104). Lower Panel B re
GTFATLSELHCDKLHVDPENFR and the representative XIC.analysis in this study correlated well with previously published
data [5,38]. As observed in our previous studies, the most pre-
valent oxidative changes between HbA and HbE were found to be
restricted to peptides containing βCys93 (an important endpoint
for free radical induced protein oxidation with Hb[5]). The differ-
ence in oxidation between other α and β residues listed in Table 2
(regardless of H2O2 amount) was negligible. To quantify changes,
extracted ion chromatograms (XICs) were generated from the
most abundant monoisotopic peak of each peptide isotopic proﬁle
and the resulting ratio differences were compared. For example,
the most abundant monoisotopic peak (860.074 m/z) represented
in Fig. 6A for the βCys93 containing peptide, GTFATL-
SELHCDKLHVDPENFR, was used to construct the resulting XIC.
Because βCys93 residue exists in either the oxidized or unoxidized
form the percentage of both isoforms were calculated based on the
sum of the XIC peak area from all charged isoforms of βCys93
peptides. To conﬁrm that the oxidized Cys93 moiety did not. XICs were generated from the most abundant monoisotopic peak of each isotopic
mass tolerance of 0.01 Da, and mass precision set to three decimals. For relative
eak area from all forms (including all charge states and versions that result from
opic proﬁle of the triply charged βC93 tryptic peptide GTFATLSELHCDKLHVDPENFR
present the isotopic proﬁle of the DMPO labeled þ4 charge βC93 tryptic peptide
Table 4
These quantitative MS data represent oxidative reactions of HbA and HbE with
ferrous α subunits and H2O2. Reactions were also performed in the presence of
AHSP.
Reaction conditions HbA Cys93 Oxidation (%) HbE Cys93 Oxidation (%)
2XH2O2 1.270.09 8.470.02
5XH2O2 3.570.04 12.370.4
2XH2O2þAHSP 1.370.07 3.170.01
5XH2O2þAHSP 0.570.1 2.670.01
Table 5
These quantitative MS data represent oxidative reactions of HbA and HbE with
ferric α subunits and H2O2. Reactions were also performed in the presence of AHSP.
Reaction conditions HbA Cys93 Oxidation (%) HbE Cys93 Oxidation (%)
2XH2O2 1.770.23 7.570.13
5XH2O2 9.370.24 14.473.2
2XH2O2þAHSP 0.470.03 Below Detection
5XH2O2þAHSP 2.770.06 3.270.7
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modiﬁcation at this cite we compared the averaged total ion cur-
rent ratio of an internal peptide (β subunit tryptic peptide
VNVDEVGGEALGR, does not get oxidized) and the C93 containing
peptide (oxidized and unoxidized); the ratio changed very little for
both Hbs regardless of the H202 condition (data not shown).
As an initial step, we performed control quantitative proteomic
experiments with HbA and HbE in 2.0 M excess H2O2; the results
from these studies show that both Hbs were oxidized at similar
levels (see Table 3). These data like the autooxidation kinetic re-
sults in this report clearly indicate that H2O2 induced oxidation is
similar between HbA and HbE. The next series of MS experiments
were aimed at probing the effect free α subunits (in the presence
of H2O2) have on oxidative stability (Tables 4 and 5). For example,
the relative abundance difference associated with a 5.0 M excess
H2O2 (with ferric free α subunits) resulted in a 3–4 fold higher
level of Cys93 oxidation for both Hbs. This trend was also observed
for experimental conditions involving ferrous free α subunits and
HbE. These data are the ﬁrst quantitative results reported that
directly link the impact of free α subunits to oxidative effects on
Hb in solutions as reﬂected by the substantial increases in HbA and
HbE βCys93 oxidation in the presence of H2O2.
To further explore and conﬁrm the oxidative impact of α sub-
units on Hb oxidation, we added alpha stabilizing protein (AHSP)
to the reaction mixture. AHSP preferentially bind ferric α subunits
(binds ferrous α subunits less tightly) to form a non-reactive
hexacoordinate ferric form which inhibits ferryl heme formation
(see Fig. 7), redox chemistry, catalysis, and heme loss [29]. Fig. 7
shows deconvoluted spectra of a typical α subunit ferryl heme
after treatment with H2O2. The resulting spectrum is characterized
by absorbance peaks at 544 and 588 nm (conﬁrmed by derivtiza-
tion with Na2S). When H2O2 is added to the reaction mixture of
ferric α subunits complexed with AHSP, the resulting spectrum
resembles a hexacoordinate hemichrome with prominent absor-
bance peaks at 535 and 565 nm conﬁrming the lack of any formed
ferryl heme [29]. The structural comparisons among the two heme
pockets in Panels B and C show that AHSP induces alternative bis-
His hexacoordination which restricts access of H2O2 to the heme in
addition to inhibiting oxidation of Fe3þto Fe4þ . Complexation of
AHSP with α subunits therefore should reduce the oxidative im-
pact which would be reﬂected by a decrease in hotspot oxidation.
As shown in Tables 4 and 5 the presence of AHSP substantially
reduced βCys93 oxidation for both proteins. The level of βCys93
oxidation for ferric α subunit experiments was reduced to nearly
undetectable levels with 2.0 M excess H2O2 (peptide precursor ioncurrent was near baseline levels preventing the Xcalibur software
from generating accurate extracted ion chromatogram) and de-
creased by more than 4 fold with 5.0 M excess H2O2. The decrease
in βCys93 oxidation was not as profound when AHSP was in-
cubated with Hbs containing ferrous α subunits which is likely
associated with the weaker afﬁnity AHSP has for the ferrous form.
Additionally, in the presence and absence of AHSP, H2O2 exposure
resulted in completely oxidizing ferrous α subunits to the ferric
state. These experiments unambiguously conﬁrm the role that
excess free α subunits have on oxidative stability of both HbA and
HbE.
Because β Cys93 has been described as a free radical endpoint
of ferryl ion and globin centered radical oxidation we performed
DMPO labeling experiments to comparatively quantify the relative
abundance of ferryl radicals in HbA and HbE. The exposure of Hbs
to H2O2 has previously been shown to initially produce a por-
phyrin cation radical (and ferryl ion) that oxidizes cysteinyl and
tyrosyl amino acids to form globin centered radicals [39]. The spin
trap label DMPO reacts with these modiﬁed amino acids to form a
nitroxide radical that is further oxidized to the corresponding
globin radical derived nitrone adduct by the ferryl moiety. These
DMPO derived adducts are stable under fragmentation conditions
used in LC-MS/MS analysis [39,40]. We therefore utilized DMPO to
characterize the Hb radicals in HbA and HbE in the presence of
H2O2 (5 fold excess relative to heme). Analyses of LC/MS/MS and
full MS data identiﬁed DMPO labeled Cys112, Tyr42α and Cys93
peptides (most prominently labeled amino acid) with the addition
of H2O2 (see Fig. 6B). DMPO Cys93 labeling in the absence of H2O2
was at negligible levels (1% for both HbA and HbE). As shown in
Table 6, the degree of DMPO labeling was similar for HbA and HbE.4. Discussion
There are well over 1000 naturally occurring human Hb var-
iants that result mostly from single point mutations in the globin
protein. Less commonly found variants are known to be associated
with multiple amino acid substitutions, deletions, and altered
post-translational processes. In general, these mutations alter Hb
structure and biochemical properties with physiological effects
ranging from insigniﬁcant to severe [41]. While several decades of
research have primarily focused on identifying Hb variants that
have altered oxygen binding afﬁnities and associated clinical
outcome, [41] very little has been done to explore the impact these
amino acid substitutions have on the variant Hb iron oxidation
state. These Hb mutants which are subjected to evolutionary
pressures are viewed as “experiments of nature” and can provide
unique model systems to address the question as to why some Hb
variants are more oxidatively stable while others develop into a
full circulatory disorder [41].
An example of an oxidatively stable Hb mutant is Hb Provi-
dence [42,43]. RBCs from patients with Hb Providence contains
two β-subunit variants with single amino acid mutations at
βLys82-Asp (βK82D) and at βLys82-Asn (βK82 N) positions;
both of these bind oxygen at lower afﬁnity than wild type HbA.
However, these variants (when isolated from native HbA) were
found to resist H2O2 induced oxidation by internalizing radicals
through the ferric/ferryl pseudoperoxidase cycle [42]. Conversely,
single amino acid variant Hbs linked to severe pathology, includ-
ing sickle cell Hb (HbS) (β6 Glu-Val) and HbE (β26 Glu-Lys), are
less oxidatively stable than HbA [9,34,41,44]. In the case of HbS,
we recently found that the ferryl form of HbS persists longer in
solutions than its HbA counterpart and as a consequence induced
self-inﬂicted modiﬁcations within the protein, and subsequent
heme loss. We have recently shown that this oxidative instability
and heme loss induces profound physiological changes (when
Fig. 7. Spectra and Model structures representing ferrous α subunits treated with 10 fold excess of H2O2 and ferric α subunits treated with 10 fold excess of H2O2 and
incubated with AHSP. Panel A: Spectra for 65 mM ferric alpha subunits incubated with and without AHSP treated with a 10 fold excess of H2O2 for 2 min followed by catalase
to remove excess peroxide. Spectrum with λmax at 544 nm and 585 nm represent ferryl heme (Feþ4) after the addition of 10 fold excess of H2O2. Spectrum with λmax at
535 nm and 565 nm represent represents the α spectrum with AHSP present. Panel B. Heme is shown using a red stick structure, distal and proximal histidines are also
shown using orange stick structures. AHSP and α-subunits are shownwith cyan and gray90 cartoon structures respectively. Panel C. Heme, distal and proximal histidines are
shown using stick structures with red and orange color respectively. α and β subunit structures are shown as cartoons with yellow and gray respectively. Models were
generated using the PyMOL Molecular Graphics System and images in both panels were generated from Protein Data Bank code 1NQP and 1LA6. (For interpretation of the
references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
Table 6
These quantitative proteomic data represent DMPO labeled Cys93.
Reaction conditions DMPO Labeled Cys93
(%)HbA
DMPO Labeled Cys93 (%)
HbE
DMPO (No H2O2) 1.170.07 2.470.21
DMPO (H2O2) 5:1
(Heme)
6.370.56 7.870.5
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tochondrial dysfunction and heme oxygenase (HO-1) translocation
to its cytosol (unpublished experiments).
Studies have indicated that HbE is oxidatively unstable. First,
drug (menadione)-induced oxidation studies of HbE (and a num-
ber of Hb variants) indicated that it oxidizes slightly faster than
HbA, and produces larger quantities of low-spin ferric Hb(hemichromes) [45]. Secondly, HbE loses heme to lipid monolayers
as well as phospholipid bilayers more readily than other variant
Hbs [46,47]. This unusual response to oxidation has an impact on
HbE structural stability and has been suggested to be an important
factor inﬂuencing the clinical course in HbE/β thalassemia patients
particularly during febrile episodes [9]. The combination of HbE
with excess unpaired α subunits (such as the case in HbE/β tha-
lassemia) syndrome has been suggested as the cause of the severe/
mild thalassemia phenotype [17,19]. α-Hb is structurally unstable,
with a tendency to denature upon oxidation, ﬁlling the cytoplasm
and cell membrane with precipitated α-globin polypeptides, free
heme, porphyrins, and iron, which further propagate ROS pro-
duction [48].
In this investigation, we sought to identify the molecular basis
of oxidative instability of HbE and to understand how this in-
stability is inﬂuenced by the presence of unmatched α subunits.
We have over the years developed (through in vitro and in vivo
M.B. Strader et al. / Redox Biology 8 (2016) 363–374 373studies) a working model that describes oxidative pathways of cell
free Hb in relation to its use as an oxygen therapeutic [7,49–51].
These oxidative reactions of Hb (described below) can be sus-
tained by oxidants such as H2O2 generated internally (autooxida-
tion) or exogenously (chemical oxidation) when H2O2 is originated
from cellular sources during oxidative stress [1,2].
We ﬁrst examined the process of spontaneous oxidation (au-
tooxidation) of both Hbs at physiological conditions; our data
show that HbE autoxidized at similar initial rates to its HbA
counterpart. Importantly, during the later stages of the auto-
oxidation process, HbE underwent extensive unfolding and pre-
cipitation. This unfolding and precipitation was completely re-
versed with the addition of catalase (H2O2 scavenger) suggesting
that H2O2 plays a key role in driving these events. This difference
in response to oxidation supports previous crystal structure data
indicating that HbE is structurally less stable than HbA as the (β26
Glu-Lys) mutation in HbE was found to disrupt salt bridges and
packing interactions necessary for optimal tertiary structure [9,18].
Next, we followed the pseudoperoxidase activities of both Hbs
after their reaction with bolus amounts of H2O2. Both ferrous
forms of HbA and HbE consumed H2O2 at approximately the same
rates, and their respective solutions were populated with almost
the same levels of ferryl species. This is further supported by the
spin trap DMPO labeling data indicated similar ferryl levels be-
tween HbA and HbE. However, when freshly prepared ferryl HbA
and HbE heme were allowed to autoreduce to their respective
ferric forms, ferryl HbE was slower in its rates of autoreduction in
the absence of outside reductant. This is signiﬁcant because a
longer lasting ferryl heme and protein radical can self-inﬂict oxi-
dative changes within the Hb protein and other biological mole-
cules. Our data further substantiates this point because we also
observed a signiﬁcant increase in HbE heme loss rate (relative to
HbA).
We employed both HPLC and mass spectrometric methods to
analyze these oxidative pathways in the two Hbs with a focus on
the β subunit, since it has been shown by our group and others to
bear the burden of these oxidative side reactions [5,32,38,52].
Speciﬁcally, βCys93 has emerged as a reliable index among a group
of amino acids of the hotspot region in Hb for Hb radicals and their
migration to this residue. The quantitative mass spectrometry re-
sults from this study clearly correlate with previous reports in-
dicating the most prevalent oxidative “hotspot” changes between
HbA and HbE to be restricted to peptides containing βCys93 (an
important endpoint for free radical induced protein oxidation with
Hb). The MS data from this report also quantitatively indicate for
the ﬁrst time that free α subunits (in the presence of H2O2) act as
oxidants and in the presence of H2O2 substantially increase βCys93
oxidation of both proteins. Intriguingly, the addition of AHSP re-
verses the oxidative impact of free α subunits on both proteins.
Since AHSP is known to bind α subunits in an inactive hex-
acoordinate conﬁguration that prevents ferryl accumulation, these
mass spectrometry results unambiguously conﬁrm the destabi-
lizing role of unpaired α subunits and shed light on the mechan-
ism behind the pathology in patients who inherit HbE/β
thalassemia.
We have recently reported differences in oxidative pathways
among α, β, and γ subunits of native and some human Hb variants
[32]. In the presence of H2O2, a β subunit mutant Bristol-Alesha
(β67(E11)Val-Met), unlike its α subunit analogue, Hb Evans (α62
(E11)Val-Met) produced larger ferryl and protein radical signals;
the proximity of this substituted methionine to the reactive ferryl
heme resulted in post-translational modiﬁcation (PTM) of the Met
67 to Asp [32]. The absence of Asp conversion in α subunits is
attributed to the presence of an α speciﬁc Tyr42 that acts as a
redox cofactor providing an electron transfer route involved in
ferryl heme iron reduction [53]. β subunits do not possess thisredox cofactor and are therefore unable to effectively reduce the
reactive ferryl responsible for the above PTM; this is supported by
the crystal structure (in the same study) revealing a long-lived
ferryl (Fe4þ¼O) complex in the β subunit but not in the α subunit
mutant. Separately, we found (in another study) that fetal Hb (γ2/
α2) exhibits an enhanced pseudoperoxidase activity and accu-
mulates less damaging ferryl iron. This ﬁnding may explain the
evolutionary advantage in possessing high levels of oxidatively
stable fetal Hb (10–20%) within RBCs on the course of both sickle
cell disease and the thalassemias [52]. The inability of HbE (an-
other β subunit variant Gluβ26 Lys) to effectively reduce its highly
damaging ferryl heme under oxidative stress is likely a con-
tributing factor for the damaging role of HbE in the erythrocyte
proteome of patients suffering from HbE/β-thalassemia.
In summary, we have shown for the ﬁrst time that unpaired α
globin (if not associated with β subunits in a tetrameric form) is
oxidatively unstable and more damaging to HbA and HbE tetra-
mers as a whole. The work here also indicates that α subunit
oxidative side reactions have a more profound impact on the β
subunit; speciﬁcally irreversible oxidation of βCys93 in the pre-
sence of H2O2 ultimately leads to β subunit unfolding and heme
loss. We have also shown that AHSP is an effective inhibitor of
both ferrous and ferric forms of α subunits. AHSP has been in-
vestigated in recent years in relationship to its role in modifying
the severity of β-thalassemia in mice models [54]. This effect
however, is less established in humans [55], although some in-
vestigations found that AHSP expression was signiﬁcantly corre-
lated to excess α subunits expression in individuals with HbE/β-
thalassemia [56]. Since the amount of free α globin chain appears
to be an important factor contributing to differences in hemato-
logic and clinical severity with β thalassemia. It remains possible
that AHSP or its mimetic could potentially offer some therapeutic
opportunities in treatment of the complications of β thalassemia
and other related conditions. Alternatively down regulation of α-
globin expression was recently suggested as a therapeutically
feasible approach using RNA interference, epigenetic drug target-
ing, or genome editing [57].Funding
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